Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: patriotism / Re: Cohen 2008 Earnings Estimates $0.09/shr

I will be pleased with $91M gross revenues to PDS with expenses less than $10M for a net to PTSC of $40.5M for the quarter.  That would mean that PDS needs only an additional $43M in MMP licensing over the next 2 months to meet the OPTIMISTIC Cohen outlook.  Keep in mind the optimistic outlook, at .09 EPS equates at a P/E of 15 to a share price of $1.35.  Not a bad start and sure beats $0.555/share!

Share
New Message
Please login to post a reply